• Ticker:- PPH;false;MVPPH;
  • Ticker Group:- ETFEQ_IND;false;;
  • How to Purchase

Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

Pharmaceutical ETF PPH

  • Full Name: Market Vectors®
    Pharmaceutical ETF (PPH)

    Management Style: Replication

    Underlying Index: Market Vectors US Listed Pharmaceutical 25 Index (MVPPHTR)

    Index Provider: Market Vectors Index Solutions

    Index Description: MVPPHTR is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NYSE Arca
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 01/27/15

    • 30-Day SEC Yield1

      1.76%
    • Total Net Assets

      $353.1M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.43%
    • Net Expense Ratio/TER2

      0.35%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      03/31/2015
  • Portfolio Composition (%)
    as of 01/27/15

    • % of Net Assets
    • Stocks

      100.25
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      -0.25
  • Download All HoldingsAll Holdings (%)as of 01/27/15

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Novartis Ag
    NVS US
    332,557
    32,899,8649.32
    Johnson & Johnson
    JNJ US
    300,525
    30,680,5988.69
    Pfizer Inc
    PFE US
    717,219
    23,381,3406.62
    Merck & Co Inc
    MRK US
    287,157
    17,964,5425.09
    Glaxosmithkline Plc
    GSK US
    396,038
    17,885,0765.07
    Sanofi
    SNY US
    375,571
    17,501,6084.96
    Novo Nordisk A/S
    NVO US
    376,227
    17,114,5664.85
    Actavis Plc
    ACT US
    59,895
    16,782,5804.75
    Allergan Inc/United States
    AGN US
    73,781
    16,656,0614.72
    Bristol-Myers Squibb Co
    BMY US
    261,493
    16,209,9514.59
    Abbvie Inc
    ABBV US
    254,864
    16,081,9184.55
    Eli Lilly & Co
    LLY US
    218,175
    15,649,6934.43
    Valeant Pharmaceuticals International I
    VRX US
    94,908
    15,261,2064.32
    Abbott Laboratories
    ABT US
    349,365
    15,260,2634.32
    Astrazeneca Plc
    AZN US
    210,531
    15,135,0744.29
    Teva Pharmaceutical Industries Ltd
    TEVA US
    243,264
    14,367,1724.07
    Shire Plc
    SHPG US
    61,950
    13,690,9503.88
    Mckesson Corp
    MCK US
    61,263
    13,337,5683.78
    Mylan Inc/Pa
    MYL US
    107,756
    6,066,1241.72
    Perrigo Co
    PRGO US
    38,623
    6,025,5741.71
    Zoetis Inc
    ZTS US
    137,543
    5,955,6121.69
    Endo Pharmaceuticals Holdings Inc
    ENDP US
    35,925
    2,864,3000.81
    Mallinckrodt Plc
    MNK US
    26,388
    2,832,2240.80
    Hospira Inc
    HSP US
    42,410
    2,777,4310.79
    Salix Pharmaceuticals Ltd
    SLXP US
    12,734
    1,608,3040.46
    Other/Cash
    -891,700-0.25
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.